Cargando…
Human Serum Albumin Based Nanodrug Delivery Systems: Recent Advances and Future Perspective
With the success of several clinical trials of products based on human serum albumin (HSA) and the rapid development of nanotechnology, HSA-based nanodrug delivery systems (HBNDSs) have received extensive attention in the field of nanomedicine. However, there is still a lack of comprehensive reviews...
Autores principales: | Li, Changyong, Zhang, Dagui, Pan, Yujing, Chen, Biaoqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459149/ https://www.ncbi.nlm.nih.gov/pubmed/37631411 http://dx.doi.org/10.3390/polym15163354 |
Ejemplares similares
-
Current advances in nanodrug delivery systems for malaria prevention and treatment
por: Kekani, Linda N., et al.
Publicado: (2023) -
Camptothecin-based nanodrug delivery systems
por: Wen, Yan, et al.
Publicado: (2017) -
Nanodrug Delivery Systems for the Treatment of Ovarian Cancer
por: Pantshwa, Jonathan M., et al.
Publicado: (2020) -
Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery
por: Qiu, Chong, et al.
Publicado: (2023) -
Recent advancements in erythrocytes, platelets, and albumin as delivery systems
por: Xu, Peipei, et al.
Publicado: (2016)